Login / Signup

Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer.

Xiaoju Max MaJohanna C BendellHerbert I HurwitzChristine JuJohn J LeeAlex LovejoyChristoph MancaoAlan NicholasRichard PriceNicolas SommerNalin TikooLijing YaoStephanie J YaungJohn F Palma
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
ctDNA quantification in post-induction plasma may serve as a prognostic biomarker for mCRC post-treatment outcomes.
Keyphrases
  • circulating tumor
  • cell free
  • metastatic colorectal cancer
  • circulating tumor cells